Areas of work

Use of sodium valproate and other anti-seizure medications in England and Wales during the COVID-19 pandemic: a population-level analysis of 60 million individuals. Preprints with The Lancet

CCU014_03: The impact of the COVID-19 pandemic on use of sodium valproate and implementation of recommendations of the Cumberlege report